Skip to content

Anti-HCV Selective High Affinity Ligands to Block HCV E2-CD81 Interaction

New compounds that block Hepatitis C virus from entering the cell and possibly reduce the potential inflammation and other pathologies.

Published: 8th May 2019
Anti-HCV Selective High Affinity Ligands to Block HCV E2-CD81 Interaction
Header image provided by the institution.
Patents
  • WO2015128744A2
IP Status
  • Patent application submitted